Sueca

Researchers are evaluating a continuity of care intervention to improve metabolic control in adults with type 2 diabetes mellitus (T2DM) in the Terres de l'Ebre health region of Catalonia. This randomized, parallel-group clinical trial is led by the Endocrinology Service at Hospital de Tortosa Verge de la Cinta (HTVC) and aims to assess whether structured, multidisciplinary training and feedback provided to primary care professionals can enhance diabetes management. The study recognizes the complexity of managing T2DM, which requires addressing glycemic control, cardiovascular risk, and multimorbidity, with HbA1c as the main measure of glycemic control. The intervention involves four endocrinologists and four nurses delivering onsite training to primary care physicians and nurses at intervention centers. The training includes six biweekly modules combining theoretical and practical content on T2DM management, cardiovascular risk reduction, and diabetic foot care. This program runs from July 2025 to July 2026, with each participating center receiving 15 sessions per year. Regular feedback on clinical performance and patient outcomes will be provided, and a qualitative component with focus groups will gather professional insights before and after the intervention. Participants are adult patients with T2DM for at least 12 months, registered in the eCAP primary care system. Data collection occurs at enrollment and at 6, 12, and 24 months after enrollment, focusing mainly on HbA1c levels. Secondary outcomes include other health indicators, professional knowledge and engagement, and organizational aspects. All data are anonymized to maintain confidentiality. The study aims to offer evidence on how a multidisciplinary continuity of care program can improve metabolic control for adults with T2DM in real-world primary care settings.